Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system
Authors
Keywords
-
Journal
Expert Review of Gastroenterology & Hepatology
Volume 12, Issue 8, Pages 811-818
Publisher
Informa UK Limited
Online
2018-07-05
DOI
10.1080/17474124.2018.1496820
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study
- (2018) M Chaparro et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Prolonged Persistence of Adalimumab Transferred From Mother to Infant During Pregnancy
- (2018) Remi Labetoulle et al. ANNALS OF INTERNAL MEDICINE
- Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines
- (2018) Dawn B. Beaulieu et al. Clinical Gastroenterology and Hepatology
- Hepatitis B Vaccination Effective in Children Exposed to Anti-Tumour Necrosis Factor Alpha in Utero
- (2018) Alison de Lima et al. Journal of Crohns & Colitis
- Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants
- (2018) Michael G. Kattah et al. Clinical and Translational Gastroenterology
- Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease
- (2017) Uma Mahadevan et al. GASTROENTEROLOGY
- Ustekinumab and Anti-Interleukin-23 Agents in Crohn's Disease
- (2017) Parakkal Deepak et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease
- (2017) Heidi Kammerlander et al. INFLAMMATORY BOWEL DISEASES
- Ustekinumab Drug Levels in Maternal and Cord Blood in a Woman With Crohn’s Disease Treated Until 33 Weeks of Gestation
- (2017) Catherine R Rowan et al. Journal of Crohns & Colitis
- Impact of inflammatory bowel disease activity and thiopurine therapy on birth weight: A meta-analysis
- (2017) Begoña Gonzalez-Suarez et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Immunological Changes in Blood of Newborns Exposed to Anti-TNF-α during Pregnancy
- (2017) Ana Esteve-Solé et al. Frontiers in Immunology
- The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies
- (2016) Alison de Lima-Karagiannis et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Decidual Control of Trophoblast Invasion
- (2016) Shipra Sharma et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?
- (2016) Arsène Mekinian et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Interleukin 23 regulates the functions of human decidual immune cells during early pregnancy
- (2016) Jun-Ying Cai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Effect of Maternal Peripartum Anti-TNFα Use on Infant Immune Response
- (2016) Sarah Sheibani et al. DIGESTIVE DISEASES AND SCIENCES
- 437 Do Infant Serum Levels of Biologic Agents at Birth Correlate With Risk of Adverse Outcomes? Results From the PIANO Registry
- (2016) Uma Mahadevan et al. GASTROENTEROLOGY
- Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection
- (2016) Mette Julsgaard et al. GASTROENTEROLOGY
- The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
- (2016) Geoffrey C. Nguyen et al. GASTROENTEROLOGY
- The safety of vedolizumab for ulcerative colitis and Crohn's disease
- (2016) Jean-Frédéric Colombel et al. GUT
- Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease
- (2016) Namita Singh et al. INFLAMMATORY BOWEL DISEASES
- Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease
- (2016) Máire A. Conrad et al. INFLAMMATORY BOWEL DISEASES
- Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer
- (2016) Charlene Porter et al. JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Differences in Cytokine Expression and STAT3 Activation between Healthy Controls and Patients of Unexplained Recurrent Spontaneous Abortion (URSA) during Early Pregnancy
- (2016) JunYing Cai et al. PLoS One
- Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy
- (2015) Rui Pereira et al. DRUG DEVELOPMENT RESEARCH
- Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety
- (2015) A de Lima et al. GUT
- Introducing Vedolizumab to Clinical Practice: Who, When, and How?
- (2015) RV Bryant et al. Journal of Crohns & Colitis
- Safety issues of biologics in pregnant patients with rheumatic diseases
- (2014) Monika Østensen Annals of the New York Academy of Sciences
- Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results
- (2014) Tim Wyant et al. GUT
- Anti-TNFα Therapies Are Safe During Pregnancy in Women with Inflammatory Bowel Disease
- (2014) Neeraj Narula et al. INFLAMMATORY BOWEL DISEASES
- Impact of Anti–Tumor Necrosis Factor Alpha Antibodies Administered to Pregnant Women With Inflammatory Bowel Disease on Long-term Outcome of Exposed Children
- (2014) Martin Bortlik et al. INFLAMMATORY BOWEL DISEASES
- Anti-TNF- Therapy May Cause Neonatal Neutropenia
- (2014) T. Guiddir et al. PEDIATRICS
- Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study
- (2013) Martin Bortlik et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Tumor necrosis factor-α inhibitor therapy and fetal risk: A systematic literature review
- (2013) Renée M Marchioni WORLD JOURNAL OF GASTROENTEROLOGY
- Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapy
- (2012) T. Bessissow et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- T-Cell Non-Hodgkin's Lymphomas Reported to the FDA AERS With Tumor Necrosis Factor-Alpha (TNF-α) Inhibitors: Results of the REFURBISH Study
- (2012) Parakkal Deepak et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Complications From Inflammatory Bowel Disease During Pregnancy and Delivery
- (2012) Gabriella Bröms et al. Clinical Gastroenterology and Hepatology
- Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
- (2012) Uma Mahadevan et al. Clinical Gastroenterology and Hepatology
- Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure
- (2012) Zuzana Zelinkova et al. Clinical Gastroenterology and Hepatology
- High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy
- (2011) Z. Zelinkova et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Role of Thiopurine and Anti-TNF Therapy in Lymphoma in Inflammatory Bowel Disease
- (2011) Lisa J Herrinton et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Intrauterine Growth Restriction: Cytokine Profiles of Trophoblast Antigen-Stimulated Maternal Lymphocytes
- (2011) Raj Raghupathy et al. Clinical & Developmental Immunology
- An imbalance in interleukin-17-producing T and Foxp3+ regulatory T cells in women with idiopathic recurrent pregnancy loss
- (2011) S. K. Lee et al. HUMAN REPRODUCTION
- Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31
- (2011) Casper Steenholdt et al. Journal of Crohns & Colitis
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Pregnancy and Pediatrics
- (2010) Uma Mahadevan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Development in the cynomolgus macaque following administration of ustekinumab, a human anti-il-12/23p40 monoclonal antibody, during pregnancy and lactation
- (2010) Pauline L. Martin et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease
- (2010) Kuldeep Cheent et al. Journal of Crohns & Colitis
- ORIGINAL ARTICLE: Treatment with Tumor Necrosis Factor Inhibitors and Intravenous Immunoglobulin Improves Live Birth Rates in Women with Recurrent Spontaneous Abortion
- (2008) Edward E. Winger et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- 499 The Effect of Maternal Peripartum Infliximab Use On Neonatal Immune Response
- (2008) Uma Mahadevan et al. GASTROENTEROLOGY
- Embryonic implantation: cytokines, adhesion molecules, and immune cells in establishing an implantation environment
- (2008) M. S. M. van Mourik et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Human Tumour Necrosis Factor: Physiological and Pathological Roles in Placenta and Endometrium
- (2008) S. Haider et al. PLACENTA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now